Premium
This is an archive article published on June 29, 2009

Biocon in pact with Mylan for biologic drugs

Biocon has signed a nagreement with Mylan to develop and manufacture biologic drugs globally.

Biotechnology firm Biocon Ltd said on Monday it has signed a definitive agreement with Mylan Inc to develop,manufacture and supply generic biologic drugs globally.

As part of the agreement,both companies will share development,capital and other costs to bring the products to market,it said in a statement.

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement